Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation

ABSTRACT We recently discovered that heat shock causes nucleolin to relocalize from the nucleolus to the nucleoplasm, whereupon it binds replication protein A and inhibits DNA replication initiation. We report that nucleolin mobilization also occurs following exposure to ionizing radiation (IR) and treatment with camptothecin. Mobilization was selective in that another nucleolar marker, upstream binding factor, did not relocalize in response to IR. Nucleolin relocalization was dependent on p53 and stress, the latter initially stimulating nucleolin-p53 complex formation. Nucleolin relocalization and complex formation in vivo were independent of p53 transactivation but required the p53 C-terminal regulatory domain. Nucleolin and p53 also interact directly in vitro, with a similar requirement for p53 domains. These data indicate a novel p53-dependent mechanism in which cell stress mobilizes nucleolin for transient replication inhibition and DNA repair.

[1]  Y. Mao,et al.  Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Samuel H. Wilson,et al.  A role for p53 in base excision repair , 2001, The EMBO journal.

[3]  N. Maizels,et al.  The C-terminal domain of nucleolin accelerates nucleic acid annealing. , 2000, Biochemistry.

[4]  C. Kostic,et al.  Isolation and characterization of sixteen novel p53 response genes , 2000, Oncogene.

[5]  Visintin,et al.  The nucleolus: the magician's hat for cell cycle tricks , 2000, Current opinion in cell biology.

[6]  J. Borowiec,et al.  Formation of a Complex between Nucleolin and Replication Protein a after Cell Stress Prevents Initiation of DNA Replication , 2000, The Journal of cell biology.

[7]  K. Vousden,et al.  Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.

[8]  T. Misteli,et al.  High mobility of proteins in the mammalian cell nucleus , 2000, Nature.

[9]  M. Bruschi,et al.  Nucleolin, a Novel Partner for the Myb Transcription Factor Family That Regulates Their Activity* , 2000, The Journal of Biological Chemistry.

[10]  E. May,et al.  Human and Mouse Fas (APO-1/CD95) Death Receptor Genes Each Contain a p53-responsive Element That Is Activated by p53 Mutants Unable to Induce Apoptosis* , 2000, The Journal of Biological Chemistry.

[11]  Hsiao-Huei Wu,et al.  MDM2--master regulator of the p53 tumor suppressor protein. , 2000, Gene.

[12]  J. Milner,et al.  Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus , 2000, Oncogene.

[13]  D. Auclair,et al.  HRad17 Colocalizes with NHP2L1 in the Nucleolus and Redistributes after UV Irradiation* , 1999, The Journal of Biological Chemistry.

[14]  M. Oren Regulation of the p53 Tumor Suppressor Protein* , 1999, The Journal of Biological Chemistry.

[15]  P. May,et al.  Twenty years of p53 research: structural and functional aspects of the p53 protein , 1999, Oncogene.

[16]  G. Schellenberg,et al.  Physical and Functional Interaction between p53 and the Werner’s Syndrome Protein* , 1999, The Journal of Biological Chemistry.

[17]  D. Gilbert,et al.  Mcm2, but Not Rpa, Is a Component of the Mammalian Early G1-Phase Prereplication Complex , 1999, The Journal of cell biology.

[18]  Y Taya,et al.  DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.

[19]  T. Unger,et al.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.

[20]  P. Bouvet,et al.  Structure and functions of nucleolin. , 1999, Journal of cell science.

[21]  A. Budde,et al.  p53 represses ribosomal gene transcription , 1999, Oncogene.

[22]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[23]  C. Iftode,et al.  Replication protein A (RPA): the eukaryotic SSB. , 1999, Critical reviews in biochemistry and molecular biology.

[24]  L. Wiesmüller,et al.  The dual role model for p53 in maintaining genomic integrity , 1999, Cellular and Molecular Life Sciences CMLS.

[25]  D. Israeli,et al.  p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs , 1998, The Journal of experimental medicine.

[26]  F. Kashanchi,et al.  Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.

[27]  C. Prives Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.

[28]  Ettore Appella,et al.  Phosphorylation of p53: a Novel Pathway for p53 Inactivation in Human T-Cell Lymphotropic Virus Type 1-Transformed Cells , 1998, Journal of Virology.

[29]  N. Rhind,et al.  The Schizosaccharomyces pombe S-phase checkpoint differentiates between different types of DNA damage. , 1998, Genetics.

[30]  P. Haluska,et al.  Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen. , 1998, Nucleic acids research.

[31]  R. Hannan,et al.  Transcription by RNA polymerase I. , 1998, Frontiers in bioscience : a journal and virtual library.

[32]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[33]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[34]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[35]  N. Maizels,et al.  Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[37]  O'Connor Pm Mammalian G1 and G2 phase checkpoints. , 1997 .

[38]  P. O'Connor Mammalian G1 and G2 phase checkpoints. , 1997, Cancer surveys.

[39]  J. Larner,et al.  S phase damage sensing checkpoints in mammalian cells. , 1997, Cancer surveys.

[40]  N. Maizels,et al.  Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein , LR 1 ( Ig y rDNA y recombination ) , 1997 .

[41]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[42]  X. Chen,et al.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. , 1996, Genes & development.

[43]  U. Knippschild,et al.  p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. , 1996, The EMBO journal.

[44]  R. Paules,et al.  DNA damage and cell cycle checkpoints , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  L. Wiesmüller,et al.  In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes , 1996, Journal of virology.

[46]  L. Cox,et al.  A direct effect of activated human p53 on nuclear DNA replication. , 1995, The EMBO journal.

[47]  T. Kohwi-Shigematsu,et al.  Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential , 1995, Molecular and cellular biology.

[48]  S. Friend,et al.  Characterization of human Gadd45, a p53-regulated protein. , 1994, The Journal of biological chemistry.

[49]  P. O'Connor,et al.  Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.

[50]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[51]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[52]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[53]  A. Levine,et al.  Mapping of the p53 and mdm-2 interaction domains. , 1993, Molecular and cellular biology.

[54]  W. Herr,et al.  Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. , 1992, Proceedings of the National Academy of Sciences of the United States of America.